Effect of boron compounds on the biological effectiveness of proton therapy
- PMID: 35754208
- DOI: 10.1002/mp.15824
Effect of boron compounds on the biological effectiveness of proton therapy
Abstract
Purpose: We assessed whether adding sodium borocaptate (BSH) or 4-borono-l-phenylalanine (BPA) to cells irradiated with proton beams influenced the biological effectiveness of those beams against prostate cancer cells to investigate if the alpha particles generated through proton-boron nuclear reactions would be sufficient to enhance the biological effectiveness of the proton beams.
Methods: We measured clonogenic survival in DU145 cells treated with 80.4-ppm BSH or 86.9-ppm BPA, or their respective vehicles, after irradiation with 6-MV X-rays, 1.2-keV/μm (low linear energy transfer [LET]) protons, or 9.9-keV/μm (high-LET) protons. We also measured γH2AX and 53BP1 foci in treated cells at 1 and 24 h after irradiation with the same conditions.
Results: We found that BSH radiosensitized DU145 cells across all radiation types. However, no difference was found in relative radiosensitization, characterized by the sensitization enhancement ratio or the relative biological effectiveness, for vehicle- versus BSH-treated cells. No differences were found in numbers of γH2AX or 53BP1 foci or γH2AX/53BP1 colocalized foci for vehicle- versus BSH-treated cells across radiation types. BPA did not radiosensitize DU145 cells nor induced any significant differences when comparing vehicle- versus BPA-treated cells for clonogenic cell survival or γH2AX and 53BP1 foci or γH2AX/53BP1 colocalized foci.
Conclusions: Treatment with 11 B, at concentrations of 80.4 ppm from BSH or 86.9 ppm from BPA, had no effect on the biological effectiveness of proton beams in DU145 prostate cancer cells. Our results agree with published theoretical calculations indicating that the contribution of alpha particles from such reactions to the total absorbed dose and biological effectiveness is negligible. We also found that BSH radiosensitized DU145 cells to X-rays, low-LET protons, and high-LET protons but that the radiosensitization was not related to DNA damage.
Keywords: alpha particles; proton-boron capture therapy; proton-boron nuclear reaction; relative biological effectiveness; sensitization enhancement ratio.
© 2022 American Association of Physicists in Medicine.
Similar articles
-
First independent validation of the proton-boron capture therapy concept.Sci Rep. 2024 Aug 20;14(1):19264. doi: 10.1038/s41598-024-69370-y. Sci Rep. 2024. PMID: 39164312 Free PMC article.
-
The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.Radiat Environ Biophys. 2015 Mar;54(1):91-102. doi: 10.1007/s00411-014-0577-y. Epub 2014 Nov 27. Radiat Environ Biophys. 2015. PMID: 25428113
-
Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.Int J Radiat Biol. 2020 Jul;96(7):868-878. doi: 10.1080/09553002.2020.1761039. Epub 2020 May 12. Int J Radiat Biol. 2020. PMID: 32339057
-
Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with 10B-Borocaptate Sodium (BSH) and 10B-Paraboronophenylalanine (BPA).Cells. 2021 Oct 26;10(11):2883. doi: 10.3390/cells10112883. Cells. 2021. PMID: 34831105 Free PMC article. Review.
-
Application of drug delivery system to boron neutron capture therapy for cancer.Expert Opin Drug Deliv. 2008 Apr;5(4):427-43. doi: 10.1517/17425247.5.4.427. Expert Opin Drug Deliv. 2008. PMID: 18426384 Review.
Cited by
-
'Cell knife' for cancer: the clinician's perspective.Front Immunol. 2025 Apr 17;16:1536355. doi: 10.3389/fimmu.2025.1536355. eCollection 2025. Front Immunol. 2025. PMID: 40313942 Free PMC article. Review.
-
Boron Nanoparticle-Enhanced Proton Therapy for Cancer Treatment.Nanomaterials (Basel). 2023 Jul 26;13(15):2167. doi: 10.3390/nano13152167. Nanomaterials (Basel). 2023. PMID: 37570485 Free PMC article.
-
Variations among glioblastoma cell lines in boron-mediated enhancement of cell killing by proton beams.Sci Rep. 2025 Aug 12;15(1):29453. doi: 10.1038/s41598-025-14658-w. Sci Rep. 2025. PMID: 40789893 Free PMC article.
-
Current State and Prospectives for Proton Boron Capture Therapy.Biomedicines. 2023 Jun 16;11(6):1727. doi: 10.3390/biomedicines11061727. Biomedicines. 2023. PMID: 37371822 Free PMC article. Review.
-
First independent validation of the proton-boron capture therapy concept.Sci Rep. 2024 Aug 20;14(1):19264. doi: 10.1038/s41598-024-69370-y. Sci Rep. 2024. PMID: 39164312 Free PMC article.
References
REFERENCES
-
- Yoon D-K, Jung J-Y, Suh TS. Application of proton boron fusion reaction to radiation therapy: a Monte Carlo simulation study. Appl Phys Lett. 2014;105(22):223507.
-
- Jung J-Y, Yoon D-K, Barraclough B, Lee HC, Suh TS, Lu B. Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): a Monte Carlo study. Oncotarget. 2017;8(24):39774-39781.
-
- Kim M-S, Law MW-M, Djeng S-K, et al. Synergy effect of alpha particles by using natural boron in proton therapy: computational verification. AIP Adv. 2019;9(11):115017.
-
- Bláha P, Feoli C, Agosteo S, et al. The proton-boron reaction increases the radiobiological effectiveness of clinical low- and high-energy proton beams: novel experimental evidence and perspectives. Front Oncol. 2021;11(2122):682647.
-
- Cirrone GAP, Manti L, Margarone D, et al. First experimental proof of proton boron capture therapy (PBCT) to enhance proton therapy effectiveness. Sci Rep. 2018;8(1):1141.
MeSH terms
Substances
Grants and funding
- TAE Life Sciences
- the Department of Radiation Physics (Department chair funds from Dr. Mary K. Martel), The University of Texas MD Anderson Cancer Center
- the Division of Radiation Oncology Strategic Initiatives, The University of Texas MD Anderson Cancer Center
- the NCI/NIH Cancer Center Support (Core) Grant P30 CA011672 to The University of Texas MD Anderson Cancer Center
LinkOut - more resources
Full Text Sources
Medical